Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11939383 B7-H4 antibodies and methods and use thereof

Patent 11939383 was granted and assigned to Five Prime Therapeutics on March, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Five Prime Therapeutics
Five Prime Therapeutics
0
Date Filed
August 28, 2020
0
Date of Patent
March 26, 2024
0
Patent Applicant
Five Prime Therapeutics
Five Prime Therapeutics
0
Patent Application Number
17006670
0
Patent Citations
‌
US Patent 7619068 Ovr110 antibody compositions and methods of use
0
‌
US Patent 7622565 Nucleic acids encoding B7-H4, a T cell immunoregulatory molecule
0
‌
US Patent 7658921 Molecules with extended half-lives, compositions and uses thereof
0
‌
US Patent 6891030 T-cell immunoregulatory molecule
0
‌
US Patent 6946292 Cells producing antibody compositions with increased antibody dependent cytotoxic activity
0
‌
US Patent 7214775 Method of modulating the activity of functional immune molecules
0
‌
US Patent 7304149 BTLA nucleic acids
0
‌
US Patent 7504256 Process for producing polypeptide
0
‌
US Patent 9447186 Antibodies to human B7x for treatment of metastatic cancer
0
‌
US Patent 9555124 B7-H3 and B7-H4, novel immunoregulatory molecules
0
•••
Patent Inventor Names
Hangil Park
0
Majid Ghoddusi
0
Nerissa Mendoza
0
Kathy Miller
0
Alessandro Palumbo
0
Charles Kaplan
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11939383
0
Patent Primary Examiner
‌
Aurora M Fontainhas
0

Find more entities like US Patent 11939383 B7-H4 antibodies and methods and use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.